5.00
+0.09(+1.83%)
Currency In USD
Address
70 Doppler
Irvine, CA 92618
United States of America
Phone
949 261 2900
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
37
First IPO Date
May 31, 2018
| Name | Title | Pay | Year Born |
| Mr. Robert A. Berman | Chief Executive Officer & Director | 760,619 | 1963 |
| Dr. Benedict Broennimann M.D. | Chief Medical Officer of Outside of United States | 240,000 | 1957 |
| Mr. Craig Thomas Glynn | Chief Financial Officer, Treasurer & Secretary | 302,226 | 1961 |
| Dr. Hamed Alavi Ph.D. | Senior Vice President & Chief Technology Officer | 371,703 | 1984 |
| Dr. Marc H. Glickman M.D. | Senior Vice President & Chief Medical Officer | 476,381 | 1949 |
| Mr. Andrew Cormack | Chief Commercial Officer | 0 | N/A |
| Mr. Warren Hancock | Co-founder | 0 | N/A |
| Ms. Sandy Prietto | Vice President of Marketing | 0 | N/A |
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.